Where does DFI USA, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), DFI USA, LLC ranks #46,141 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does DFI USA, LLC hold?

DFI USA, LLC holds 5 US utility patents granted between 2018 and 2024, spanning 4 technology areas.

What is DFI USA, LLC's Innovation Score?

DFI USA, LLC has an Innovation Score of 29.9 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does DFI USA, LLC focus on?

DFI USA, LLC's top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 4 patents. Grants appear in 4 CPC subclasses total.

Is DFI USA, LLC's patent grant rate increasing or decreasing?

DFI USA, LLC's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for DFI USA, LLC's patents?

DFI USA, LLC's patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the DFI USA, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

DFI USA, LLC

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, DFI ranks #46,141 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.

#46,141
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.9/100): 16.6
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R46141 · US Corporation #46,141 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,141/49,997
PHOTO-FINISH Deutsches Zentrum…
CPC-NARROW C07C · 4 areas
INNOV-THIN 29.9/100
CLAIMS-RICH 16.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Deutsches Zentrum FUR Neurodegenrative Erkankung (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
DFI USA · this assignee

30
3D Lighting… · lowest

7

What this shows DFI's Innovation Score is 29.9/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where DFI's grants concentrate

DFI USA, LLC is a focused PatentsView assignee: 4 CPC subclasses with 80% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). By volume, DFI sits between Deutsches Zentrum FUR Neurodegenrative Erkankung and Diageo Ireland.

DFI's three-year grant acceleration

DFI USA, LLC shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Deutsches Zentrum…

5
Deuve Photonics

5
Devilbiss Healthc…

5
Dexos Drinks

5
Dgel Electrosystem

5
DGM Creations

5
DH

5
Diageo Ireland

5
DFI USA ◀

5

What this shows DFI holds 5 patents at rank #46,076, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near DFI

By rank, the assignees closest to #46,076 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in DFI's primary technology class.

DFI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

DFI USA, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	20.0%
2019	1	20.0%
2021	1	20.0%
2023	1	20.0%
2024	1	20.0%

Which technologies does DFI USA, LLC patent most?

C07C - Acyclic OR Carbocyclic Compounds 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

C25B - Electrolytic OR Electrophoretic Processes FOR THE Production OF Compounds OR NON-METALS; Apparatus Therefor 2

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#46,141

of 49,997 tracked assignees

Innovation Score

29.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

DFI USA, LLC's patent record in context - here's where to go next.

DFI USA, LLC's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 80% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #46,141 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare DFI USA, LLC against Deutsches Zentrum FUR Neurodegenrative Erkankung, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.